Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Phytomedicine ; 93: 153761, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34715512

ABSTRACT

BACKGROUND: Premna herbacea Roxb., a perennial herb is well documented for its therapeutic uses among the traditional health care-givers of Assam, India. Scientific validation on the traditional use of the medicinal plant using modern technology may promote further research in health care. PURPOSE: This study evaluates the therapeutic potential of methanolic extract of P. herbacea (MEPH) against type 2 diabetes mellitus (T2DM) and its phytochemical(s) in ameliorating insulin resistance (IR), thereby endorsing the plant bioactives as effective anti-hyperglycemic agents. METHODS: The anti-diabetic potential of the plant extract was explored both in L6 muscle cells and high fructose high fat diet (HF-HFD) fed male Sprague Dawley (SD) rats. Bioactivity guided fractionation and isolation procedure yielded Verbascoside and Isoverbascoside (ISOVER) as bioactive and major phytochemicals in P. herbacea. The bioenergetics profile of bioactive ISOVER and its anti-hyperglycemic potential was validated in vitro by XFe24 analyzer, glucose uptake assay and intracellular ROS generation by flourometer, FACS and confocal microscopy. The potential of ISOVER was also checked by screening various protein markers via immunoblotting. RESULTS: MEPH enhanced glucose uptake in FFA-induced insulin resistant (IR) L6 muscle cells and decreased elevated blood glucose levels in HF-HFD fed rats. Isoverbascoside (ISOVER) was identified as most bioactive phytochemical for the first time from the plant in the Premna genus. ISOVER activated the protein kinase B/AMP-activated protein kinase signaling cascades and enhanced glucose uptake in IR-L6 muscle cells. ISOVER decreased the phosphorylation of p38 mitogen-activated protein kinase (p38MAPK) and c-Jun N-terminal kinase (JNK) and increased that of mammalian target of rapamycin (mTOR), thereby attenuating IR. However, molecular docking revealed that ISOVER increases insulin sensitivity by targeting the JNK1 kinase as a competitive inhibitor rather than mTOR. These findings were further supported by the bioenergetics profile of ISOVER. CONCLUSION: This study for the first time depicts the functional properties of ISOVER, derived from Premna herbacea, in ameliorating IR. The phytochemical significantly altered IR with enhanced glucose uptake and inhibition of ROS through JNK-AKT/mTOR signaling which may pave the way for further research in T2DM therapeutics.


Subject(s)
Diabetes Mellitus, Type 2 , Insulin Resistance , Animals , Diabetes Mellitus, Type 2/drug therapy , Energy Metabolism , Glucose , Glucosides , Insulin/metabolism , Male , Molecular Docking Simulation , Muscle Cells/metabolism , Phenols , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Sprague-Dawley , TOR Serine-Threonine Kinases/metabolism
2.
Bioorg Med Chem Lett ; 28(13): 2270-2274, 2018 07 15.
Article in English | MEDLINE | ID: mdl-29803730

ABSTRACT

The synthesis of steroid hormones is critical to human physiology and improper regulation of either the synthesis of these key molecules or activation of the associated receptors can lead to disease states. This has led to intense interest in developing compounds capable of modulating the synthesis of steroid hormones. Compounds capable of inhibiting Cyp19 (Aromatase), a key enzyme in the synthesis of estrogens, have been successfully employed as breast cancer therapies, while inhibitors of Cyp17 (17α-hydroxylase-17,20-lyase), a key enzyme in the synthesis of glucocorticoids, mineralocorticoids and steroidal sex hormones, are a key component of prostate cancer therapy. Inhibition of CYP17 has also been suggested as a possible target for the treatment of Cushing Syndrome and Metabolic Syndrome. We have identified two novel series of stilbene based CYP17 inhibitors and demonstrated that exemplary compounds in these series have pharmacokinetic properties consistent with orally delivered drugs. These findings suggest that compounds in these classes may be useful for the treatment of diseases and conditions associated with improper regulation of glucocorticoids synthesis and glucocorticoids receptor activation.


Subject(s)
Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics , Drug Design , Piperazines/pharmacokinetics , Steroid 17-alpha-Hydroxylase/antagonists & inhibitors , Stilbenes/pharmacokinetics , Animals , Cytochrome P-450 Enzyme Inhibitors/chemical synthesis , Cytochrome P-450 Enzyme Inhibitors/chemistry , Guinea Pigs , Half-Life , Microsomes, Liver/metabolism , Piperazines/chemical synthesis , Piperazines/chemistry , Stereoisomerism , Stilbenes/chemical synthesis , Stilbenes/chemistry , Structure-Activity Relationship
3.
Bioorg Med Chem Lett ; 26(23): 5825-5829, 2016 12 01.
Article in English | MEDLINE | ID: mdl-27789139

ABSTRACT

Metabolic Syndrome, also referred to as 'Syndrome X' or 'Insulin Resistance Syndrome,' remains a major, unmet medical need despite over 30years of intense effort. Recent research suggests that there may be a causal link between this condition and abnormal glucocorticoid processing. Specifically, dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) axis leads to increased systemic cortisol concentrations. Cushing' syndrome, a disorder that is also typified by a marked elevation in levels of cortisol, produces clinical symptomology that is similar to those observed in MetS, and they can be alleviated by decreasing circulating cortisol concentrations. As a result, it has been suggested that decreasing systemic cortisol concentration might have a positive impact on the progression of MetS. This could be accomplished through inhibition of enzymes in the cortisol synthetic pathway, 11ß-hydroxylase (Cyp11B1), 17α-hydroxylase-C17,20-lyase (Cyp17), and 21-hydroxylase (Cyp21). We have identified a series of novel sulfonamide analogs of (2S,4R)-Ketoconazole that are potent inhibitors of these enzymes. In addition, selected members of this class of compounds have pharmacokinetic properties consistent with orally delivered drugs, making them well suited to further investigation as potential therapies for MetS.


Subject(s)
Cytochrome P-450 Enzyme Inhibitors/chemistry , Cytochrome P-450 Enzyme Inhibitors/pharmacology , Ketoconazole/analogs & derivatives , Ketoconazole/pharmacology , Metabolic Syndrome/drug therapy , Sulfonamides/chemistry , Sulfonamides/pharmacology , Animals , Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics , Drug Design , Female , Guinea Pigs , Humans , Ketoconazole/pharmacokinetics , Male , Metabolic Syndrome/enzymology , Sulfonamides/pharmacokinetics
4.
Chemistry ; 16(42): 12627-41, 2010 Nov 08.
Article in English | MEDLINE | ID: mdl-20878800

ABSTRACT

Streptococcus pneumoniae LTA is a highly complex glycophospholipid that consists of nine carbohydrate residues: three glucose, two galactosamine and two 2-acetamino-4-amino-2,4,6-trideoxygalactose (AATDgal) residues that are each differently linked, one ribitol and one diacylated glycerol (DAG) residue. Suitable building blocks for the glucose and the AATDgal residues were designed and their synthesis is described in this paper. These building blocks permitted the successful synthesis of the core structure Glcß(1-3)AATDgalß(1-3)Glcα(1-O)DAG in a suitably protected form for further chain extension (1 b, 1 c) and as unprotected glycolipid (1 a) that was employed in biological studies. These studies revealed that 1 a as well as 1 lead to interleukin-8 release, however not via TLR2 or TLR4 as receptor.


Subject(s)
Lipopolysaccharides/chemical synthesis , Streptococcus pneumoniae/immunology , Teichoic Acids/chemical synthesis , Glycolipids/chemistry , HEK293 Cells , Humans , Interleukin-8/blood , Interleukin-8/drug effects , Lipopolysaccharides/blood , Lipopolysaccharides/chemistry , Lipopolysaccharides/metabolism , Molecular Structure , Streptococcus pneumoniae/chemistry , Teichoic Acids/blood , Teichoic Acids/chemistry , Teichoic Acids/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism
5.
Org Biomol Chem ; 4(18): 3521-5, 2006 Sep 21.
Article in English | MEDLINE | ID: mdl-17036149

ABSTRACT

The phytotoxic lactone herbarumin III has been synthesized in 11% overall yield. The approach applied uses Keck's asymmetric allylation and Sharpless epoxidation to build the key fragment. Esterification with 5-hexenoic acid and a ring closing metathesis was used to arrive at the target.


Subject(s)
Lactones/chemistry , Lactones/chemical synthesis , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...